Healthcare & Life Sciences News and Articles

Google News – Biopharma External News

Why China’s biotech rise is harder to contain than AI - ThinkChina

news.google.com · 09 Sep 2026

Google News – Biopharma External News

[Big read] Is Singapore the ultimate ‘China+1’ biopharma hub? - ThinkChina

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

As China embraces AI, few US pharmaceutical execs bet on it for innovation - South China Morning Post

news.google.com · 09 Sep 2026

Industry News External News

As China embraces AI, only 24% of US pharma execs bet on it for drug-making - South China Morning Post

news.google.com · 09 Sep 2026

Google News – Biopharma External News

Beyond China: Five other overseas destinations for biopharma dollars - BioSpace

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Heart Failure Trial Data Might Change The Case For Investing In Lexicon Pharmaceuticals (LXRX) - simplywall.st

news.google.com · 09 Sep 2026

Google News – FDA (biotech/pharma) External News

Health Check: ‘Frustrated’ Echo IQ ponders next move after shock FDA setback - Stockhead

news.google.com · 09 Sep 2026

Google News – Clinical Trials External News

What Is Brenipatide? All About the New Long-Acting GLP-1 Drug - Healthline

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Asm. John McDonald pushes for greater pharmaceutical drug price transparency - spectrumlocalnews.com

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy - Macau Business

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock - The Globe and Mail

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock - The Motley Fool

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock - Yahoo Finance

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Vertex Pharmaceuticals (VRTX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Hepion Pharmaceuticals Raises $500,000 Via 8% Secured Convertible Note With Gravitas, 12.5M Warrants - TradingView

news.google.com · 09 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Why China’s biotech rise is harder to contain than AI - ThinkChina

[Big read] Is Singapore the ultimate ‘China+1’ biopharma hub? - ThinkChina

As China embraces AI, few US pharmaceutical execs bet on it for innovation - South China Morning Post

As China embraces AI, only 24% of US pharma execs bet on it for drug-making - South China Morning Post

Beyond China: Five other overseas destinations for biopharma dollars - BioSpace

Heart Failure Trial Data Might Change The Case For Investing In Lexicon Pharmaceuticals (LXRX) - simplywall.st

Health Check: ‘Frustrated’ Echo IQ ponders next move after shock FDA setback - Stockhead

What Is Brenipatide? All About the New Long-Acting GLP-1 Drug - Healthline

Asm. John McDonald pushes for greater pharmaceutical drug price transparency - spectrumlocalnews.com

Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy - Macau Business

Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock - The Globe and Mail

Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock - The Motley Fool

Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock - Yahoo Finance

Vertex Pharmaceuticals (VRTX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance

Hepion Pharmaceuticals Raises $500,000 Via 8% Secured Convertible Note With Gravitas, 12.5M Warrants - TradingView